Heurtaux T, Bouvier D, Bnani A, Helgueta S, Frauenknecht K, Mittelbronn M, Sinkkonen L (2022) Normal and pathological NRF2 signalling in the central nervous system
The integration of continuous glucose monitors (CGM) with peptide therapy allows real-time feedback on metabolic responses
Clinical trials are governed by strict regulatory frameworks overseen by the MHRA, and all adverse events including serious adverse events must be reported and investigated by the trial sponsor and investigators in accordance with Good Clinical Practice (GCP) guidelines and MHRA pharmacovigilance requirements
Sucrosomial iron: A new generation iron for improving oral supplementation
Kinetic Optimization in Myogenic Research: Evaluating the Splice-Variant Specificity of IGF-1LR3 and IGF-DES Explore the dynamic differences between IGF-1LR3 and IGF-DES to discover which muscle-healing peptide is right for your unique recovery, fat loss, and performance goals